U.S. Consumer Genomics Market Size, Share & Trends Analysis Report By Application (Genetic Relatedness, Ancestry, Diagnostics, Sport Nutrition & Health, Reproductive Health), And Segment Forecasts, 2024 - 2030
- Report ID: GVR-4-68040-243-0
- Number of Pages: 80
- Format: Electronic (PDF)
- Historical Range: 2018 - 2023
- Industry: Healthcare
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Application
1.2.2. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in U.S.
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application Outlook
2.3. Competitive Insights
Chapter 3. U.S. Consumer Genomics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rise in interest of consumers & physicians in DTC kits & consequent rise in sales of DNA test kits
3.2.1.2. Increase in access to DTC services due to reducing cost of genotyping
3.2.1.3. Expansion in applications of DTC genetics
3.2.1.3.1. Health testing
3.2.1.3.2. Ancestry
3.2.1.3.3. Genetic relatedness
3.2.1.4. Significant investments & initiatives by companies to maintain their competitive edge in the market
3.2.1.5. Growing trend of personalized genomics
3.2.2. Market restraint analysis
3.2.2.1. Ethical and clinical issues pertaining to the use of DTC products & personalized treatment
3.2.2.2. Regulatory challenges pertaining to the use of DTC genetic tests
3.3. U.S. Consumer Genomics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Threat of new entrant
3.3.1.2. Threat of substitues
3.3.1.3. Bargaining power of buyers
3.3.1.4. Bargaining power of suppliers
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & legal landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
Chapter 4. U.S. Consumer Genomics Market: Application Estimates & Trend Analysis
4.1. U.S. Consumer Genomics Market: Application Dashboard
4.2. U.S. Consumer Genomics Market: Application Movement Analysis
4.3. U.S. Consumer Genomics Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.4. Genetics Relatedness
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Ancestry
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Lifestyle, Wellness, & Nutrition
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Diagnostics
4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Sports Nutrition & Health
4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.9. Reproductive Health
4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.10. Personalized Medicine & Pharmacogenetic Testing
4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.11. Others
4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Competitive Landscape
5.1. Recent Developments & Impact Analysis, By Key Market Participants
5.2. Company/Competition Categorization
5.3. Vendor Landscape
5.3.1. List of key distributors and channel partners
5.3.2. Key customers
5.3.3. Key company market share analysis, 2023
5.3.4. Ancestry
5.3.4.1. Company overview
5.3.4.2. Financial performance
5.3.4.3. Product benchmarking
5.3.4.4. Strategic initiatives
5.3.5. Gene By Gene, Ltd. (FamilyTree DNA)
5.3.5.1. Company overview
5.3.5.2. Financial performance
5.3.5.3. Product benchmarking
5.3.5.4. Strategic initiatives
5.3.6. 23andMe, Inc.
5.3.6.1. Company overview
5.3.6.2. Financial performance
5.3.6.3. Product benchmarking
5.3.6.4. Strategic initiatives
5.3.7. Color Health, Inc
5.3.7.1. Company overview
5.3.7.2. Financial performance
5.3.7.3. Product benchmarking
5.3.7.4. Strategic initiatives
5.3.8. Myriad Genetics, Inc
5.3.8.1. Company overview
5.3.8.2. Financial performance
5.3.8.3. Product benchmarking
5.3.8.4. Strategic initiatives
5.3.9. Mapmygenome
5.3.9.1. Company overview
5.3.9.2. Financial performance
5.3.9.3. Product benchmarking
5.3.9.4. Strategic initiatives
5.3.10. Helix OpCo LLC
5.3.10.1. Company overview
5.3.10.2. Financial performance
5.3.10.3. Product benchmarking
5.3.10.4. Strategic initiatives
5.3.11. MyHeritage Ltd.
5.3.11.1. Company overview
5.3.11.2. Financial performance
5.3.11.3. Product benchmarking
5.3.11.4. Strategic initiatives
5.3.12. Pathway Genomics
5.3.12.1. Company overview
5.3.12.2. Financial performance
5.3.12.3. Product benchmarking
5.3.12.4. Strategic initiatives
5.3.13. Veritas
5.3.13.1. Company overview
5.3.13.2. Financial performance
5.3.13.3. Product benchmarking
5.3.13.4. Strategic initiatives
5.3.14. Amgen, Inc.
5.3.14.1. Company overview
5.3.14.2. Financial performance
5.3.14.3. Product benchmarking
5.3.14.4. Strategic initiatives
5.3.15. Diagnomics, Inc.
5.3.15.1. Company overview
5.3.15.2. Financial performance
5.3.15.3. Product benchmarking
5.3.15.4. Strategic initiatives
5.3.16. Toolbox Genomics
5.3.16.1. Company overview
5.3.16.2. Financial performance
5.3.16.3. Product benchmarking
5.3.16.4. Strategic initiatives
5.3.17. SomaLogic, Inc.
5.3.17.1. Company overview
5.3.17.2. Financial performance
5.3.17.3. Product benchmarking
5.3.17.4. Strategic initiatives
5.3.18. inui Health (formerly Scanadu)
5.3.18.1. Company overview
5.3.18.2. Financial performance
5.3.18.3. Product benchmarking
5.3.18.4. Strategic initiatives
5.3.19. QuickCheck Health
5.3.19.1. Company overview
5.3.19.2. Financial performance
5.3.19.3. Product benchmarking
5.3.19.4. Strategic initiatives
5.3.20. Illumina, Inc.
5.3.20.1. Company overview
5.3.20.2. Financial performance
5.3.20.3. Product benchmarking
5.3.20.4. Strategic initiatives
List of Tables
1. List of abbreviations
2. U.S. Consumer Genomics Market, by Application, 2018 - 2030 (USD Million)
List of Figures
1. U.S. consumer genomics market segmentation
2. Market research process
3. Data triangulation techniques
4. Primary research pattern
5. Value chain-based sizing & forecasting
6. QFD modelling for market share assessment
7. Market formulation & validation
8. Market snapshot
9. End-use and end-use segment snapshot
10. Sales channel and age segment snapshot
11. Competitive landscape snapshot
12. Market dynamics
13. Porter’s Five Forces analysis
14. PESTLE analysis
15. U.S. consumer genomics market: Application outlook and key takeaways
16. U.S. consumer genomics market: Application movement analysis
17. Genetic relatedness market estimates and forecast, 2018 - 2030 (USD Million)
18. Ancestry market estimates and forecast, 2018 - 2030 (USD Million)
19. Lifestyle, wellness, & nutrition market estimates and forecast, 2018 - 2030 (USD Million)
20. Diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
21. Sports nutrition & health market estimates and forecast, 2018 - 2030 (USD Million)
22. Reproductive health market estimates and forecast, 2018 - 2030 (USD Million)
23. Personalized medicine & pharmacogenetic testing market estimates and forecast, 2018 - 2030 (USD Million)
24. Others market estimates and forecast, 2018 - 2030 (USD Million)
25. Company market share analysis, 2023
26. Strategic framework
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
